167 related articles for article (PubMed ID: 18718550)
1. Serum platelet-activating factor acetylhydrolase activity: a novel potential inflammatory marker in type 1 diabetes.
Gomes MB; Cobas RA; Nunes E; Nery M; Castro-Faria-Neto HC; Tibiriçá E
Prostaglandins Other Lipid Mediat; 2008 Dec; 87(1-4):42-6. PubMed ID: 18718550
[TBL] [Abstract][Full Text] [Related]
2. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus.
Gomes MB; Cobas RA; Nunes E; Castro-Faria-Neto HC; da Matta MF; Neves R; Tibiriçá E
Diabetes Res Clin Pract; 2009 Jul; 85(1):61-8. PubMed ID: 19464746
[TBL] [Abstract][Full Text] [Related]
3. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor acetylhydrolase activity in patients with chronic stable angina (preliminary results).
Tănăseanu C; Moldoveanu E; Kosaka T; Neagu M; Tănăseanu S; Popescu M; Tamşulea I; Urban A
Rom J Intern Med; 2003; 41(2):145-52. PubMed ID: 15526499
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Brites FD; Verona J; Schreier LE; Fruchart JC; Castro GR; Wikinski RL
Arch Med Res; 2004; 35(3):235-40. PubMed ID: 15163466
[TBL] [Abstract][Full Text] [Related]
6. Maternal and fetal plasma platelet-activating factor acetylhydrolase activity and distribution in pre-eclampsia.
Fan P; Liu XH; He GL; Zhang S; Zhang JX; Bai H
Pediatr Res; 2012 Oct; 72(4):426-31. PubMed ID: 22797139
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome.
Rizos E; Tambaki AP; Gazi I; Tselepis AD; Elisaf M
Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):203-9. PubMed ID: 15664305
[TBL] [Abstract][Full Text] [Related]
8. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
Unno N; Sakaguchi T; Nakamura T; Yamamoto N; Sugatani J; Miwa M; Konno H
J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of IL-12 concentration, PAF-AH, and PLA(2) activity in patients with type 1 diabetes treated with intensive insulin therapy.
Wegner M; Araszkiewicz A; Pioruńska-Mikołajczak A; Zozulińska-Ziółkiewicz D; Wierusz-Wysocka B; Pioruńska-Stolzmann M
Clin Biochem; 2009 Nov; 42(16-17):1621-7. PubMed ID: 19651120
[TBL] [Abstract][Full Text] [Related]
10. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
[TBL] [Abstract][Full Text] [Related]
11. Bovine platelet-activating factor acetylhydrolase (PAF-AH) activity related to fertility.
Turk R; Juretić D; Geres D; Bacić G; Milesević M; Flegar-Mestrić Z; Turk N; Svetina A
Anim Reprod Sci; 2008 May; 105(3-4):344-53. PubMed ID: 17442508
[TBL] [Abstract][Full Text] [Related]
12. Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.
Kom GD; Schwedhelm E; Maas R; Schneider L; Benndorf R; Böger RH
Br J Clin Pharmacol; 2007 Jun; 63(6):672-9. PubMed ID: 17214829
[TBL] [Abstract][Full Text] [Related]
13. Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus.
Derbent A; Kargili A; Koca C; Gümüş Iİ; Sevgili S; Simavli S; Karakurt F; Turhan NÖ
Gynecol Endocrinol; 2011 Feb; 27(2):128-33. PubMed ID: 20504094
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor acetylhydrolase (PAF-AH) activity in patients with type 1 diabetes mellitus.
de Castro SH; Faria Neto HC; Gomes MB
Arq Bras Cardiol; 2007 Feb; 88(2):179-84. PubMed ID: 17384835
[TBL] [Abstract][Full Text] [Related]
15. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.
Kujiraoka T; Iwasaki T; Ishihara M; Ito M; Nagano M; Kawaguchi A; Takahashi S; Ishi J; Tsuji M; Egashira T; Stepanova IP; Miller NE; Hattori H
J Lipid Res; 2003 Oct; 44(10):2006-14. PubMed ID: 12867534
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
Fan P; Liu H; Wang Y; Zhang F; Bai H
Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.
Vadas P; Gold M; Perelman B; Liss GM; Lack G; Blyth T; Simons FE; Simons KJ; Cass D; Yeung J
N Engl J Med; 2008 Jan; 358(1):28-35. PubMed ID: 18172172
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.
Kujiraoka T; Hattori H; Ito M; Nanjee MN; Ishihara M; Nagano M; Iwasaki T; Cooke CJ; Olszewski WL; Stepanova IP; Egashira T; Miller NE
Atherosclerosis; 2004 Sep; 176(1):57-62. PubMed ID: 15306175
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin slow-release lowers platelet-activating factor acetyl hydrolase activity: a placebo-controlled trial in patients with type 2 diabetes.
Winkler K; Abletshauser C; Friedrich I; Hoffmann MM; Wieland H; März W
J Clin Endocrinol Metab; 2004 Mar; 89(3):1153-9. PubMed ID: 15001601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
